Lumida
/LMRI
⌘K
LMRI

LMRI

LMRI
$11.49USD↑+2.68%+0.30 today

MARKET CAP

1.1B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$11 – $12

52W RANGE

$6
$19

AI Summary

Stalk
TrimMedium

LMRI has broken a key multi‐week support cluster in a Stage 3 distribution, confirming medium-term bearish control despite an intact long-term uptrend. Price is flailing around the converged EMAs after the support failure, so immediate selling risks catching a short-covering bounce. We will trim into strength on a retest of the broken support and moving averages as preferred execution zones.

  • ↑Q2 2026 adjusted EPS of $0.20 vs $0.16 expected; net income $2.7 M turnaround.
  • ↑Record free cash flow in Q2 2026 supports growth initiatives or buybacks.
  • ↓Profitability under pressure as operational costs constrain margins.
Full analysis →
Sales, Adj.
No data
Gross Profit, Adj.
No data
EBITDA, Adj.
No data
EBIT
No data
Net Income
No data